Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Prepaid Assets (2018 - 2025)

10x Genomics (TXG) has disclosed Prepaid Assets for 8 consecutive years, with $22.2 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 14.42% to $22.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.2 million through Dec 2025, up 14.42% year-over-year, with the annual reading at $22.2 million for FY2025, 14.42% up from the prior year.
  • Prepaid Assets hit $22.2 million in Q4 2025 for 10x Genomics, up from $19.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $25.6 million in Q1 2025 to a low of $13.3 million in Q2 2021.
  • Historically, Prepaid Assets has averaged $18.4 million across 5 years, with a median of $19.0 million in 2022.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 103.52% in 2021 and later fell 10.0% in 2024.
  • Year by year, Prepaid Assets stood at $13.9 million in 2021, then increased by 19.3% to $16.6 million in 2022, then increased by 13.34% to $18.8 million in 2023, then increased by 3.31% to $19.4 million in 2024, then grew by 14.42% to $22.2 million in 2025.
  • Business Quant data shows Prepaid Assets for TXG at $22.2 million in Q4 2025, $19.2 million in Q3 2025, and $20.4 million in Q2 2025.